Table 1.
Main characteristics of healthy donors and HIV-infected patients.
| HD (n = 27) | HIV (n = 27) | |
|---|---|---|
| Gender (M/F), n | 15/12 | 16/11 |
| Age (years), mean ± SD | 45.5 ± 13.4 | 51.9 ± 11.7 |
| Time from diagnosis (years), mean ± SD | 26.9 ± 16.9 | |
| PVL* (log RNA copies/μL), mean ± SD | 1.77 ± 0.37 | |
| PVL0 (log RNA copies/μL), mean ± SD | 4.00 ± 1.02 | |
| PVL1 (log RNA copies/μL), mean ± SD | 2.25 ± 0.77 | |
| CD4+ T* (cells/μL), mean ± SD | 768.9 ± 283.1 | |
| CD4+ T0 (cells/μL), mean ± SD | 377.5 ± 389.9 | |
| CD4+ T1 (cells/μL), mean ± SD | 679.0 ± 252.7 |
Gender and age are reported for healthy donors (HD) and HIV-infected patients (HIV). Time from HIV-1 diagnosis as well as plasma viral load (PVL) and CD4+ T cells counts at the time of blood collection
(*)
, before
(0)
and after
(1)
the start of anti-retroviral therapy (ART) were included for HIV-infected patients. The detection limit of PVL was 1.70 log HIV-1 RNA copies/ml. M, males; F, females; n, number of individuals; SD, standard deviation.